Etanidazole
 | |
| Names | |
|---|---|
| IUPAC name
N-(2-Hydroxyethyl)-2-(2-nitro-1H-imidazol-1-yl)acetamide | |
| Identifiers | |
22668-01-5  | |
| ChEMBL | ChEMBL47405  |
| ChemSpider | 3161 |
| Jmol interactive 3D | Image |
| PubChem | 3276 |
| UNII | 30DKA3Q1HL |
| |
| |
| Properties | |
| C7H10N4O4 | |
| Molar mass | 214.18 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| verify (what is ?) | |
| Infobox references | |
Etanidazole is a nitroimidazole drug used for its radiosensitizing properties. Administration of etanidazole results in a decrease of glutathione concentration and inhibits glutathione S-transferase.[1] The result is that tissues become more sensitive to the ionizing radiation used in cancer treatment.
See also
- EF5, a related nitroimidazole
- Misonidazole
References
- ↑ Definition of etanidazole, National Cancer Institute Drug Dictionary.
This article is issued from Wikipedia - version of the Thursday, June 25, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.